Skip to main content

Filters

Evidence

Handbooks/Manuals

News

What are the benefits and risks of treating endometrioma before women have fertility treatment?

Key messages

  • There is no clear benefit to any of the treatment options, which include medicines and different types of surgery, to improve the chances of women becoming pregnant. Current guidance for women to discuss their medical history, egg supply, and personal wishes with their clinician remains.

  • Better studies are urgently needed to help guide decision-making by women and their doctors.

What is endometrioma?

Endometriosis is a common condition where tissue similar to the lining of the womb grows outside of it and is linked to infertility. One type of endometriosis, called endometrioma (cysts on the ovary), is common in women having trouble getting pregnant. However, doctors are unsure how best to treat these cysts before fertility treatments such as IVF (in vitro fertilisation). There are many options to treat endometrioma which include both medicines and different types of surgery, as well as not treating the endometrioma before fertility treatment.

What did we want to find out?
We wanted to find out:

  • whether treating endometrioma (either with medicine or surgery) before starting fertility treatment improves the chances of having a baby;

  • whether any of these treatments are safe.

What did we do?
We searched for studies that compared different ways of managing endometrioma (any type of medicine or surgery compared with another type of medicine or surgery or sham treatment) before starting fertility treatment.

What did we find?

We found 7 studies involving 646 women. Studies took place in either Turkey (3), Iran (2), Egypt or Japan.

  • Some women had medicine (gonadotropin-releasing hormone agonists (GnRH) compared to control) to suppress endometriosis before starting in vitro fertilisation treatment (IVF).

  • Others had surgery to remove or drain the cysts before IVF. The surgical options that were tried included: endometrioma aspiration, cystectomy (removal of the tissue) and transvaginal sclerotherapy (shrinkage with scarring agents) which were compared to control (no surgery).

  • Some women had no treatment before starting IVF.

Main results

  • It is unclear whether treating the endometrioma with medicine or surgery before IVF had any effect on live birth, number of embryos available, viable pregnancy or pregnancy loss.

  • There was no information on the number of embryo procedures, age of the infant at delivery, birthweight, or death of the infant at birth.

  • Only one study reported possible unwanted effects or complications from abnormalities and there were none reported.

What are the limitations of the evidence?

There is no clear evidence that treating endometrioma before IVF improves the chance of having a baby. All studies had issues such as small participant numbers or unclear results; therefore, we have very little confidence in the findings. . Better studies are urgently needed to guide future treatment decisions.

How up to date is the evidence?

This review updates our previous review. The evidence is up-to-date to October 2025.

Background

Endometriomata are cysts of endometriosis in the ovaries. As artificial reproductive technology (ART) cycles involve oocyte pickup from the ovaries, endometriomata may interfere with the outcome of ART.

Objectives

To assess the effects of surgery, medical treatment, combination therapy (both medical and surgical) or no treatment for improving reproductive outcomes among women with endometrioma, prior to undergoing ART cycles.

Search strategy

We searched the Cochrane Gynaecology and Fertility Group's specialised register, CENTRAL, MEDLINE, Embase and PsycINFO on 7 October 2025. We also searched trial registries, checked reference lists of relevant studies and contacted experts in the field for any additional trials.

Selection criteria

Randomised controlled trials of any medical, surgical or combination therapy or expectant management for endometriomata prior to ART.

Data collection and analysis

The trials were independently identified and assessed for risk of bias by two authors. The authors of the trials that were potentially eligible for inclusion were contacted for additional information. Outcomes were expressed as Peto odds ratios and mean differences (MD).

Main results

Eleven trials were identified of which seven were excluded and four with 312 participants were included.

No trial reported live birth outcomes. One trial compared gonadotropin-releasing hormone (GnRH) agonist with GnRH antagonist. There was no evidence of a difference for clinical pregnancy rate (CPR), however the number of mature oocytes retrieved (NMOR) was greater with GnRH agonists (MD -1.60, 95% CI -2.44 to -0.76) and the ovarian response was increased (estradiol (E2) levels on day of human chorionic gonadotropin (hCG) injection) (MD -456.30, 95% CI -896.06 to -16.54).

Surgery (aspiration or cystectomy) versus expectant management (EM) showed no evidence of a benefit for clinical pregnancy with either technique. Aspiration was associated with greater NMOR (MD 0.50, 95% CI 0.02 to 0.98) and increased ovarian response (E2 levels on day of hCG injection) (MD 685.3, 95% CI 464.50 to 906.10) compared to EM.Cystectomy was associated with a decreased ovarian response to controlled ovarian hyperstimulation (COH) (MD -510.00, 95% CI -676.62 to -343.38); no evidence of an effect on the NMOR compared to EM. Aspiration versus cystectomy showed no evidence of a difference in CPR or the NMOR.

Authors' conclusions

This narrative review highlights the uncertainties regarding the management of endometrioma prior to ART. There is no high-certainty evidence that might change the current guidance for management plans to be developed on an individual basis, taking into account previous outcomes, ovarian reserve, and patient's wishes. Further robust, adequately powered studies are required to guide future clinical decision-making which include critical outcomes as per the core outcome set for endometriosis.

Funding

This Cochrane review had no dedicated funding.

Registration

Protocol (2010) https://doi.org/10.1002/14651858.CD008571.

Original review (2010) https://doi.org/10.1002/14651858.CD008571.pub2.

Citation
Harlow K, Igbokwe N, Bortoletto P, Farquhar C, Duffy JMN, Craciunas L. Interventions for women with endometrioma prior to assisted reproductive technology. Cochrane Database of Systematic Reviews 2026, Issue 11. Art. No.: CD008571. DOI: 10.1002/14651858.CD008571.pub3.

Our use of cookies

We use necessary cookies to make our site work. We'd also like to set optional analytics cookies to help us improve it. We won't set optional cookies unless you enable them. Using this tool will set a cookie on your device to remember your preferences. You can always change your cookie preferences at any time by clicking on the 'Cookies settings' link in the footer of every page.
For more detailed information about the cookies we use, see our Cookies page.

Accept all
Configure